|
Vaccines – Successive Deliveries Of Vaccines For Szpzlo Warszawa Białołęka-Targówek. Vaccine Against Diphtheria, Tetanus, Pertussis (Acellular, Composite), Adsorbed, With Reduced Antigen Content - Part 1,Vaccine Against Diphtheria, Tetanus, Pertussis (Acellular, Composite), Adsorbed, With Reduced Antigen Content - Part 2,Poliovirus Vaccine - Part 3,Hepatitis A Vaccine For Adults - Part 4,Meningococcal Group B Vaccine (Rdna), Composite, Adsorbed - Part 5,Vaccine Against Diphtheria, Tetanus, Pertussis (Acellular, Composite) And Poliomyelitis (Inactivated), Adsorbed, With Reduced Antigen Content - Part 6,Human Papillomavirus Vaccine (Types 16 And 18) - Part 7,9-Valent Human Papillomavirus Vaccine - Part 8,Hepatitis B Vaccine For Children 10 Mg - Ampoules - Part 9,Hepatitis B Vaccine For Adults At A Dose Of 20 Mcg - Ampoules - Part 10,Vaccine To Protect Against The Virus That Causes Hepatitis B - Part 11,Vaccine Against Tick-Borne Meningitis For Children From 1 To 15 Years Of Age - Part 12,Vaccine Against Tick-Borne Meningoencephalitis For Adults And Children Over 16 Years Of Age - Part 13,Hepatitis A Vaccine For Children - Part 14,Hepatitis A Vaccine For Adults - Part 15,Combined Vaccine Against Diphtheria, Tetanus, Pertussis (Acellular, Combined), Hepatitis B, Poliomyelitis (Inactivated), Haemophilus Type B - Part 16,Combined Vaccine Against Diphtheria, Tetanus, Pertussis (Three-Antigen), Hepatitis B, Poliomyelitis (Inactivated), Haemofilus Influenzae Type B - Part 17,Combined Vaccine Against Diphtheria, Tetanus, Pertussis, Poliomyelitis And Haemofilus Influenzae Type B - Part 18,Combined Vaccine Against Diphtheria, Tetanus, Pertussis, Poliomyelitis And Haemofilus Influenzae Type B - Part 19,Polysaccharide Conjugate Vaccine Against Meningococci Groups A, C, W-135 And Y For Children Over 2 Years Of Age - Part 20,Vaccine Against Infections Caused By Neisseria Meningitidis Group C - Part 21,Conjugate Vaccine Against Meningococci Groups A, C, W135 And Y For Children Over 12 Months - Part 22,Pneumococcal Vaccine, Polysaccharide, Conjugate, 13-Valent - Part 23,3-Component Vaccine (Combined), Directed Against Measles, Mumps And Rubella - Part 24,Vaccine Indicated For The Prevention Of Shingles And Herpes Zoster Neuralgia (Long-Lasting Nerve Pain Following Shingles) In People Aged 50 Years And Older And Adults At Increased Risk Of Shingles - Part 25,Pneumococcal Vaccine Administered To Immunize Infants And Children Against Diseases Caused By Memorrhagic Pneumonia Infection - Part 26,Vaccine Intended For The Immunization Of Previously Unimmunized Adults And Adolescents From The Age Of 16 Years At Risk Of Infection With Hepatitis A And B Viruses - Part 27,Chickenpox Vaccine - Part 28,Vaccine To Prevent Invasive Disease And Pneumonia - Part 29,Vaccine For Active Immunization Against Yellow Fever In Travelers - Part 30,Oral Vaccine Against The Bacteria Called Salmonella Typhi That Causes Typhoid Fever - Part 31,Vaccine To Provide Protection Against Cholera In Adults And Children 2 Years Of Age And Older - Part 32,Vaccine Indicated For The Prevention Of Rabies In Children And Adults - Part 33,Dengue Vaccine - Part 34,Respiratory Syncytial Virus (Rsv) Vaccine, Indicated For People Over 60 Years Of Age - Part 35,Vaccine To Prevent Lung (Respiratory) Disease Caused By A Virus Called Respiratory Syncytial Virus (Rsv) - Part 36,Vaccine For Active Immunization Of Persons Aged ≥12 Months Against Invasive Meningococcal Disease Caused By N. Meni
|
